Sign inJoin waitlistJoin the waitlist

Carmen Calfa

Clinical Research Lead, Breast Site Disease Group · University of Miami/Jackson Health System

Credentials: · · · · ·

History

University of Miami/Jackson Health System
Present
University of Miami/Jackson Health System
Present

Medical Oncology
2001–2003
Internal Medicine
Jackson Memorial Hospital
1998–2001
University of Medicine and Pharmacy of Tirgu-Mures
1990–1994

Research

Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)
Nature Communications · 2020 · 54 citations
Improved Survival of HER2+ Breast Cancer Patients Treated with Trastuzumab and Chemotherapy Is Associated with Host Antibody Immunity against the HER2 Intracellular Domain
Cancer Research · 2016 · 49 citations
Implementation and Feasibility of an Electronic Health Record-Integrated Patient-Reported Outcomes Symptom and Needs Monitoring Pilot in Ambulatory Oncology
JCO Oncology Practice · 2022 · 37 citations

Jessica MacIntyre
5 papers
Matthew Schlumbrecht
5 papers
Alejandra Perez
2 papers
Donald Northfelt
2 papers
EP
Edith Perez
2 papers
Mark Pegram
2 papers
RC
Raphael Clynes
2 papers
Winston Tan
2 papers
A Diaz
1 paper
Abdulrahman Sinno
1 paper
Alexandra Kharazi
1 paper
Armando Giuliano
1 paper

Clinical trials

Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women With Hormone Receptor Positive Advanced Breast Cancer
Principal investigator · Recruiting
University of Miami
2024–2029
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Site PI · Recruiting · Phase 2
American Society of Clinical Oncology
2016–2028
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Sub-investigator · Recruiting · Phase 3
BriaCell Therapeutics Corporation
2023–2028